Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones

Background: Urinary stones (urolithiasis) have been categorized as kidney stones (renal calculus), ureteric stones (ureteral calculus and ureterolith), bladder stones (bladder calculus), and urethral stones (urethral calculus); however, the mechanisms underlying their promotion and related injuries...

Full description

Saved in:
Bibliographic Details
Main Authors: Takanobu Takata, Shinya Inoue, Kenshiro Kunii, Togen Masauji, Junji Moriya, Yoshiharu Motoo, Katsuhito Miyazawa
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diseases
Subjects:
Online Access:https://www.mdpi.com/2079-9721/13/1/7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588669262757888
author Takanobu Takata
Shinya Inoue
Kenshiro Kunii
Togen Masauji
Junji Moriya
Yoshiharu Motoo
Katsuhito Miyazawa
author_facet Takanobu Takata
Shinya Inoue
Kenshiro Kunii
Togen Masauji
Junji Moriya
Yoshiharu Motoo
Katsuhito Miyazawa
author_sort Takanobu Takata
collection DOAJ
description Background: Urinary stones (urolithiasis) have been categorized as kidney stones (renal calculus), ureteric stones (ureteral calculus and ureterolith), bladder stones (bladder calculus), and urethral stones (urethral calculus); however, the mechanisms underlying their promotion and related injuries in glomerular and tubular cells remain unclear. Although lifestyle-related diseases (LSRDs) such as hyperglycemia, type 2 diabetic mellitus, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, and cardiovascular disease are risk factors for urolithiasis, the underlying mechanisms remain unclear. Recently, heat shock protein 90 (HSP90) on the membrane of HK-2 human proximal tubular epithelium cells has been associated with the adhesion of urinary stones and cytotoxicity. Further, HSP90 in human pancreatic and breast cells can be modified by various advanced glycation end-products (AGEs), thus affecting their function. Hypothesis 1: We hypothesized that HSP90s on/in human proximal tubular epithelium cells can be modified by various types of AGEs, and that they may affect their functions and it may be a key to reveal that LSRDs are associated with urolithiasis. Hypothesis 2: We considered the possibility that Japanese traditional medicines for urolithiasis may inhibit AGE generation. Of Choreito and Urocalun (the extract of <i>Quercus salicina</i> Blume/<i>Quercus stenophylla</i> Makino) used in the clinic, Choreito is a Kampo medicine, while Urocalun is a characteristic Japanese traditional medicine. As Urocalun contains quercetin, hesperidin, and <i>p</i>-hydroxy cinnamic acid, which can inhibit AGE generation, we hypothesized that Urocalun may inhibit the generation of AGE-modified HSP90s in human proximal tubular epithelium cells.
format Article
id doaj-art-056c7fdac73441b0bb75a6dfe98dfc0b
institution Kabale University
issn 2079-9721
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj-art-056c7fdac73441b0bb75a6dfe98dfc0b2025-01-24T13:29:14ZengMDPI AGDiseases2079-97212025-01-01131710.3390/diseases13010007Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary StonesTakanobu Takata0Shinya Inoue1Kenshiro Kunii2Togen Masauji3Junji Moriya4Yoshiharu Motoo5Katsuhito Miyazawa6Division of Molecular and Genetic Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, JapanDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, JapanDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, JapanDepartment of Pharmacy, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, JapanDepartment of General Internal Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, JapanDepartment of Internal Medicine, Fukui Saiseikai Hospital, Wadanaka 918-8503, Fukui, JapanDepartment of Urology, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, JapanBackground: Urinary stones (urolithiasis) have been categorized as kidney stones (renal calculus), ureteric stones (ureteral calculus and ureterolith), bladder stones (bladder calculus), and urethral stones (urethral calculus); however, the mechanisms underlying their promotion and related injuries in glomerular and tubular cells remain unclear. Although lifestyle-related diseases (LSRDs) such as hyperglycemia, type 2 diabetic mellitus, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, and cardiovascular disease are risk factors for urolithiasis, the underlying mechanisms remain unclear. Recently, heat shock protein 90 (HSP90) on the membrane of HK-2 human proximal tubular epithelium cells has been associated with the adhesion of urinary stones and cytotoxicity. Further, HSP90 in human pancreatic and breast cells can be modified by various advanced glycation end-products (AGEs), thus affecting their function. Hypothesis 1: We hypothesized that HSP90s on/in human proximal tubular epithelium cells can be modified by various types of AGEs, and that they may affect their functions and it may be a key to reveal that LSRDs are associated with urolithiasis. Hypothesis 2: We considered the possibility that Japanese traditional medicines for urolithiasis may inhibit AGE generation. Of Choreito and Urocalun (the extract of <i>Quercus salicina</i> Blume/<i>Quercus stenophylla</i> Makino) used in the clinic, Choreito is a Kampo medicine, while Urocalun is a characteristic Japanese traditional medicine. As Urocalun contains quercetin, hesperidin, and <i>p</i>-hydroxy cinnamic acid, which can inhibit AGE generation, we hypothesized that Urocalun may inhibit the generation of AGE-modified HSP90s in human proximal tubular epithelium cells.https://www.mdpi.com/2079-9721/13/1/7ureteric stonelifestyle-related diseaseheat shock protein 90advanced glycation end-productsMG-H1argpyrimidine
spellingShingle Takanobu Takata
Shinya Inoue
Kenshiro Kunii
Togen Masauji
Junji Moriya
Yoshiharu Motoo
Katsuhito Miyazawa
Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
Diseases
ureteric stone
lifestyle-related disease
heat shock protein 90
advanced glycation end-products
MG-H1
argpyrimidine
title Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
title_full Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
title_fullStr Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
title_full_unstemmed Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
title_short Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones
title_sort advanced glycation end product modified heat shock protein 90 may be associated with urinary stones
topic ureteric stone
lifestyle-related disease
heat shock protein 90
advanced glycation end-products
MG-H1
argpyrimidine
url https://www.mdpi.com/2079-9721/13/1/7
work_keys_str_mv AT takanobutakata advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT shinyainoue advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT kenshirokunii advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT togenmasauji advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT junjimoriya advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT yoshiharumotoo advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones
AT katsuhitomiyazawa advancedglycationendproductmodifiedheatshockprotein90maybeassociatedwithurinarystones